These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 20959865)
1. Genome-wide association of breast cancer: composite likelihood with imputed genotypes. Politopoulos I; Gibson J; Tapper W; Ennis S; Eccles D; Collins A Eur J Hum Genet; 2011 Feb; 19(2):194-9. PubMed ID: 20959865 [TBL] [Abstract][Full Text] [Related]
2. Composite likelihood-based meta-analysis of breast cancer association studies. Politopoulos I; Gibson J; Tapper W; Ennis S; Eccles D; Collins A J Hum Genet; 2011 May; 56(5):377-82. PubMed ID: 21390041 [TBL] [Abstract][Full Text] [Related]
3. Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium. Pasaniuc B; Zaitlen N; Lettre G; Chen GK; Tandon A; Kao WH; Ruczinski I; Fornage M; Siscovick DS; Zhu X; Larkin E; Lange LA; Cupples LA; Yang Q; Akylbekova EL; Musani SK; Divers J; Mychaleckyj J; Li M; Papanicolaou GJ; Millikan RC; Ambrosone CB; John EM; Bernstein L; Zheng W; Hu JJ; Ziegler RG; Nyante SJ; Bandera EV; Ingles SA; Press MF; Chanock SJ; Deming SL; Rodriguez-Gil JL; Palmer CD; Buxbaum S; Ekunwe L; Hirschhorn JN; Henderson BE; Myers S; Haiman CA; Reich D; Patterson N; Wilson JG; Price AL PLoS Genet; 2011 Apr; 7(4):e1001371. PubMed ID: 21541012 [TBL] [Abstract][Full Text] [Related]
4. Analysis of untyped SNPs: maximum likelihood and imputation methods. Hu YJ; Lin DY Genet Epidemiol; 2010 Dec; 34(8):803-15. PubMed ID: 21104886 [TBL] [Abstract][Full Text] [Related]
5. Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping. Ellis NA; Kirchhoff T; Mitra N; Ye TZ; Chuai S; Huang H; Nafa K; Norton L; Neuhausen S; Gordon D; Struewing JP; Narod S; Offit K Genet Epidemiol; 2006 Jan; 30(1):48-61. PubMed ID: 16206141 [TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study of susceptibility loci for breast cancer in Sardinian population. Palomba G; Loi A; Porcu E; Cossu A; Zara I; Budroni M; Dei M; Lai S; Mulas A; Olmeo N; Ionta MT; Atzori F; Cuccuru G; Pitzalis M; Zoledziewska M; Olla N; Lovicu M; Pisano M; Abecasis GR; Uda M; Tanda F; Michailidou K; Easton DF; Chanock SJ; Hoover RN; Hunter DJ; Schlessinger D; Sanna S; Crisponi L; Palmieri G BMC Cancer; 2015 May; 15():383. PubMed ID: 25956309 [TBL] [Abstract][Full Text] [Related]
7. Effects of single SNPs, haplotypes, and whole-genome LD maps on accuracy of association mapping. Maniatis N; Collins A; Morton NE Genet Epidemiol; 2007 Apr; 31(3):179-88. PubMed ID: 17285621 [TBL] [Abstract][Full Text] [Related]
9. ATRIUM: testing untyped SNPs in case-control association studies with related individuals. Wang Z; McPeek MS Am J Hum Genet; 2009 Nov; 85(5):667-78. PubMed ID: 19913122 [TBL] [Abstract][Full Text] [Related]
10. CHROMSCAN: genome-wide association using a linkage disequilibrium map. Collins A; Lau W J Hum Genet; 2008; 53(2):121-126. PubMed ID: 18043862 [TBL] [Abstract][Full Text] [Related]
11. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Udler MS; Meyer KB; Pooley KA; Karlins E; Struewing JP; Zhang J; Doody DR; MacArthur S; Tyrer J; Pharoah PD; Luben R; Bernstein L; Kolonel LN; Henderson BE; Le Marchand L; Ursin G; Press MF; Brennan P; Sangrajrang S; Gaborieau V; Odefrey F; Shen CY; Wu PE; Wang HC; Kang D; Yoo KY; Noh DY; Ahn SH; Ponder BA; Haiman CA; Malone KE; Dunning AM; Ostrander EA; Easton DF; Hum Mol Genet; 2009 May; 18(9):1692-703. PubMed ID: 19223389 [TBL] [Abstract][Full Text] [Related]
12. Using family-based imputation in genome-wide association studies with large complex pedigrees: the Framingham Heart Study. Chen MH; Huang J; Chen WM; Larson MG; Fox CS; Vasan RS; Seshadri S; O'Donnell CJ; Yang Q PLoS One; 2012; 7(12):e51589. PubMed ID: 23284720 [TBL] [Abstract][Full Text] [Related]
13. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. Agarwal D; Pineda S; Michailidou K; Herranz J; Pita G; Moreno LT; Alonso MR; Dennis J; Wang Q; Bolla MK; Meyer KB; Menéndez-Rodríguez P; Hardisson D; Mendiola M; González-Neira A; Lindblom A; Margolin S; Swerdlow A; Ashworth A; Orr N; Jones M; Matsuo K; Ito H; Iwata H; Kondo N; ; ; Hartman M; Hui M; Lim WY; Iau PT; Sawyer E; Tomlinson I; Kerin M; Miller N; Kang D; Choi J-; Park SK; Noh D-; Hopper JL; Schmidt DF; Makalic E; Southey MC; Teo SH; Yip CH; Sivanandan K; Tay W-; Brauch H; Brüning T; Hamann U; ; Dunning AM; Shah M; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Schmidt MK; Broeks A; Rosenberg EH; van't Veer LJ; Fasching PA; Renner SP; Ekici AB; Beckmann MW; Shen C-; Hsiung C-; Yu J-; Hou M-; Blot W; Cai Q; Wu AH; Tseng C-; Van Den Berg D; Stram DO; Cox A; Brock IW; Reed MW; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Zheng W; Deming-Halverson S; Shrubsole MJ; Long J; Shu X-; Lu W; Gao Y-; Zhang B; Radice P; Peterlongo P; Manoukian S; Mariette F; Sangrajrang S; McKay J; Couch FJ; Toland AE; ; Yannoukakos D; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Marme F; Burwinkel B; Guénel P; Truong T; Sanchez M; Mulot C; Bojesen SE; Nordestgaard BG; Flyer H; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Mannermaa A; Kataja V; Kosma V-; Hartikainen JM; Lambrechts D; Yesilyurt BT; Floris G; Leunen K; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Wang X; Olson JE; Vachon C; Purrington K; Giles GG; Severi G; Baglietto L; Haiman CA; Henderson BE; Schumacher F; Marchand LL; Simard J; Dumont M; Goldberg MS; Labréche F; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Devilee P; Tollenaar RA; Seynaeve C; García-Closas M; Chanock SJ; Lissowska J; Figueroa JD; Czene K; Eriksson M; Humphreys K; Darabi H; Hooning MJ; Kriege M; Collée JM; Tilanus-Linthorst M; Li J; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Bogdanova N; Dörk T; Hall P; Chenevix-Trench G; Easton DF; Pharroah PD; Arias-Perez JI; Zamora P; Benítez J; Milne RL Br J Cancer; 2014 Feb; 110(4):1088-100. PubMed ID: 24548884 [TBL] [Abstract][Full Text] [Related]
14. Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. O'Donovan MC; Norton N; Williams H; Peirce T; Moskvina V; Nikolov I; Hamshere M; Carroll L; Georgieva L; Dwyer S; Holmans P; Marchini JL; Spencer CC; Howie B; Leung HT; Giegling I; Hartmann AM; Möller HJ; Morris DW; Shi Y; Feng G; Hoffmann P; Propping P; Vasilescu C; Maier W; Rietschel M; Zammit S; Schumacher J; Quinn EM; Schulze TG; Iwata N; Ikeda M; Darvasi A; Shifman S; He L; Duan J; Sanders AR; Levinson DF; Adolfsson R; Osby U; Terenius L; Jönsson EG; Cichon S; Nöthen MM; Gill M; Corvin AP; Rujescu D; Gejman PV; Kirov G; Craddock N; Williams NM; Owen MJ; Mol Psychiatry; 2009 Jan; 14(1):30-6. PubMed ID: 18813210 [TBL] [Abstract][Full Text] [Related]
15. Using imputed genotype data in the joint score tests for genetic association and gene-environment interactions in case-control studies. Song M; Wheeler W; Caporaso NE; Landi MT; Chatterjee N Genet Epidemiol; 2018 Mar; 42(2):146-155. PubMed ID: 29178451 [TBL] [Abstract][Full Text] [Related]
16. Imputation of genotypes from low density (50,000 markers) to high density (700,000 markers) of cows from research herds in Europe, North America, and Australasia using 2 reference populations. Pryce JE; Johnston J; Hayes BJ; Sahana G; Weigel KA; McParland S; Spurlock D; Krattenmacher N; Spelman RJ; Wall E; Calus MP J Dairy Sci; 2014 Mar; 97(3):1799-811. PubMed ID: 24472132 [TBL] [Abstract][Full Text] [Related]
17. FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: results of a case control study in Japan. Kawase T; Matsuo K; Suzuki T; Hiraki A; Watanabe M; Iwata H; Tanaka H; Tajima K Int J Cancer; 2009 Oct; 125(8):1946-52. PubMed ID: 19582883 [TBL] [Abstract][Full Text] [Related]
18. One thousand genomes imputation in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium aggressive prostate cancer genome-wide association study. Machiela MJ; Chen C; Liang L; Diver WR; Stevens VL; Tsilidis KK; Haiman CA; Chanock SJ; Hunter DJ; Kraft P; Prostate; 2013 May; 73(7):677-89. PubMed ID: 23255287 [TBL] [Abstract][Full Text] [Related]
19. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study. Andersen SW; Trentham-Dietz A; Figueroa JD; Titus LJ; Cai Q; Long J; Hampton JM; Egan KM; Newcomb PA Menopause; 2013 Mar; 20(3):354-8. PubMed ID: 23435034 [TBL] [Abstract][Full Text] [Related]
20. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study. Teraoka SN; Bernstein JL; Reiner AS; Haile RW; Bernstein L; Lynch CF; Malone KE; Stovall M; Capanu M; Liang X; Smith SA; Mychaleckyj J; Hou X; Mellemkjaer L; Boice JD; Siniard A; Duggan D; Thomas DC; ; Concannon P Breast Cancer Res; 2011; 13(6):R114. PubMed ID: 22087758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]